OriGene Technologies, Inc. — Form D
OriGene Technologies, Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2015-06-09. The offering totals $32.0M, of which $17.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-06-09
- Form: D
- Accession: 0001557269-15-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $32.0M
- Amount sold: $17.1M
- Remaining: $15.0M
- Investors: 5
- Date of first sale: 2015-05-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-241371
Issuer
- Name: OriGene Technologies, Inc.
- CIK: 0001557269
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9620 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Phone: 301-340-3188
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Tom Bluth | Director | Rockville, MD |
| Lanchun Duan | Director | Rockville, MD |
| Anil Gupta | Director | Rockville, MD |
| Wei-Wu He | Director | Rockville, MD |
| Beatrice Leung | Director | Rockville, MD |
| Ellen Shih | Director | Rockville, MD |
| Amy Tang | Director | Rockville, MD |
| Quan ZHOU | Director | Rockville, MD |
| Rich Hamer | Executive Officer | Rockville, MD |
| Wei-Wu He | Executive Officer | Rockville, MD |
| James Hu | Executive Officer | Rockville, MD |
| Karl Kovacs | Executive Officer | Rockville, MD |
| Youmin Shu | Executive Officer | Rockville, MD |
| Tony Su | Director | Rockville, MD |
| Gene Dove | Executive Officer | Rockville, MD |
Other filings by this issuer (3)
More